Abbott (ABT) Announces FDA Approves Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The FDA has approved the Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy, manufacturer Abbott announced in a press release.
The Proclaim XR spinal cord stimulation (SCS) system can provide relief to patients with diabetic peripheral neuropathy (DPN) in need of alternatives to traditional approaches, such as oral medication.
The U.S. Food and Drug Administration (FDA) approved Abbott's Eterna spinal cord stimulation (SCS) system for the treatment of chronic painThis neuromodulation device provides an optimized experience with